Bioscience News - GEG Tech top picks
8.8K views | +0 today
Follow
Bioscience News - GEG Tech top picks
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
Scoop.it!

A major Alzheimer's drug just failed a key trial

A major Alzheimer's drug just failed a key trial | Bioscience News - GEG Tech top picks | Scoop.it
BigField GEG Tech's insight:

A key drug to treat Alzheimer's disease failed a late-stage clinical trial, Eli Lilly and Company said Wednesday.

The drug, solanezumab, wasn't able to slow down cognitive decline in patients with Alzheimer's compared with those who took a placebo.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

CLINICAL TRIALS RESULTS AND NEW DATA ANALYSES IN AMYLOID-RELATED THERAPIES FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2015

CLINICAL TRIALS RESULTS AND NEW DATA ANALYSES IN AMYLOID-RELATED THERAPIES FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2015 | Bioscience News - GEG Tech top picks | Scoop.it
The Alzheimer's Association International Conference is the world's largest gathering of dementia researchers.
BigField GEG Tech's insight:

WASHINGTON, DC, July 22, 2015 – Clinical trial results from three studies of investigational therapies related to amyloid protein were presented at the Alzheimer’s Association International Conference® 2015 (AAIC® 2015) in Washington, D.C.


www.geg-tech.com/Vectors

No comment yet.